| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.004 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.004 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.005 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |